<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Biomerieux Sa — News on 6ix</title>
<link>https://6ix.com/company/biomerieux-sa</link>
<description>Latest news and press releases for Biomerieux Sa on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 18 Feb 2026 14:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/biomerieux-sa" rel="self" type="application/rss+xml" />
<item>
<title>bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality</title>
<link>https://6ix.com/company/biomerieux-sa/news/biomerieux-launches-smartbiometm-to-help-food-manufacturers-gain-deeper-insights-into-spoilage-and-protect-product-quality-1</link>
<guid isPermaLink="true">https://6ix.com/company/biomerieux-sa/news/biomerieux-launches-smartbiometm-to-help-food-manufacturers-gain-deeper-insights-into-spoilage-and-protect-product-quality-1</guid>
<pubDate>Wed, 18 Feb 2026 14:30:00 GMT</pubDate>
<description>bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to help food manufacturers better understand, control and prevent microbiological spoilage. By combining high‑precision DNA sequencing, advanced bioinformatics and bioMérieux's microbiology expertise, SMARTBIOME™ provides actionable insights to protect product quality, reduce waste and better preserve consumer safety.</description>
</item>
<item>
<title>Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors</title>
<link>https://6ix.com/company/biomerieux-sa/news/commonwealth-fusion-systems-names-stephane-bancel-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/biomerieux-sa/news/commonwealth-fusion-systems-names-stephane-bancel-to-board-of-directors</guid>
<pubDate>Mon, 12 Jan 2026 13:00:00 GMT</pubDate>
<description>Commonwealth Fusion Systems (CFS), the largest and leading private fusion company, today announced that Stephane Bancel, the Chief Executive Officer of Moderna Inc. who led that company's successful development, production, scaling, and global adoption of the COVID-19 vaccine, has joined as an Independent Member of the Board of Directors.</description>
</item>
<item>
<title>OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence</title>
<link>https://6ix.com/company/biomerieux-sa/news/ohiohealth-partners-with-biomerieux-as-newest-global-antimicrobial-stewardship-center-of-excellence-1</link>
<guid isPermaLink="true">https://6ix.com/company/biomerieux-sa/news/ohiohealth-partners-with-biomerieux-as-newest-global-antimicrobial-stewardship-center-of-excellence-1</guid>
<pubDate>Tue, 26 Aug 2025 18:00:00 GMT</pubDate>
<description>bioMérieux, a world leader in in vitro diagnostics, is proud to announce Columbus, Ohio, based, not-for-profit healthcare system, OhioHealth and The OhioHealth Microbiology Laboratory is the nation's newest Antimicrobial Stewardship (AMS) Center of Excellence.</description>
</item>
<item>
<title>bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM</title>
<link>https://6ix.com/company/biomerieux-sa/news/biomerieux-develops-game-changing-quality-control-solution-gene-upr-pro-hrm</link>
<guid isPermaLink="true">https://6ix.com/company/biomerieux-sa/news/biomerieux-develops-game-changing-quality-control-solution-gene-upr-pro-hrm</guid>
<pubDate>Tue, 05 Aug 2025 18:44:00 GMT</pubDate>
<description>bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the launch of GENE-UP® PRO HRM—the first DNA-based test commercially developed to detect heat-resistant molds at the molecular level.</description>
</item>
<item>
<title>bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance</title>
<link>https://6ix.com/company/biomerieux-sa/news/biomerieux-receives-fda-510k-clearance-for-its-vitekr-compact-pro-a-new-idast-system-to-fight-against-antimicrobial-resistance</link>
<guid isPermaLink="true">https://6ix.com/company/biomerieux-sa/news/biomerieux-receives-fda-510k-clearance-for-its-vitekr-compact-pro-a-new-idast-system-to-fight-against-antimicrobial-resistance</guid>
<pubDate>Tue, 18 Mar 2025 16:26:00 GMT</pubDate>
<description>bioMérieux, a world leader in the field of in vitro diagnostics, announces the U.S. Food and Drug Administration (FDA) 510(k) clearance for VITEK® COMPACT PRO. This innovative system for microorganism identification (ID) and antibiotic susceptibility testing (AST) will benefit clinical laboratories to help diagnose infectious diseases and combat antimicrobial resistance, and industrial laboratories to identify contaminants for ensuring consumer safety.</description>
</item>
<item>
<title>bioMérieux Receives Health Canada Approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel</title>
<link>https://6ix.com/company/biomerieux-sa/news/biomerieux-receives-health-canada-approval-for-the-biofirer-spotfirer-respiratorysore-throat-rst-panel</link>
<guid isPermaLink="true">https://6ix.com/company/biomerieux-sa/news/biomerieux-receives-health-canada-approval-for-the-biofirer-spotfirer-respiratorysore-throat-rst-panel</guid>
<pubDate>Tue, 25 Feb 2025 11:00:00 GMT</pubDate>
<description>bioMérieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel. This approval marks a significant advancement in how we approach public health and address today's healthcare challenges associated with respiratory infections and sore throats.</description>
</item>
</channel>
</rss>